Emery Pharma Attending the American Academy of Ophthalmology (AAO) Annual Meeting 2024
Emery Pharma is proud to announce that their CEO, Dr. Ron Najafi and CMO, Dr. Kathryn Najafi-Tagol, the inventors of Avenova®, the leading product to treat dry eye due to Blepharitis. They will be attending the American Academy of Ophthalmology (AAO) Annual Meeting, taking place in Chicago from October 18–21, 2024.
Emery Pharma’s executive management team will be highlighting their expertise in bioanalysis, specifically related to the analysis of active pharmaceutical ingredients (API) in drug products and various biological matrices such as aqueous humor, vitreous, blood, and plasma. Dr. Najafi will also discuss Emery Pharma’s capabilities with biologics, including the assessment of known or unknown proteins using their high-resolution mass spectrometry system. Additionally, Emery Pharma offers established facilities for in-vivo studies, with access to New Zealand Albino rabbits, allowing them to conduct comprehensive pharmacokinetic and toxicokinetic studies. With a proven track record of excellence in bioanalysis within the ophthalmology sector, Emery Pharma will be available throughout the meeting to discuss our capabilities and how to advance your program.
- Event: American Academy of Ophthalmology (AAO) Annual Meeting 2024
- Dates: October 19-20, 2024
- Location: Chicago, IL at the McCormick Place
“We are excited to attend this year’s AAO annual meeting in Chicago,” said Dr. Ron Najafi, CEO of Emery Pharma. “Ophthalmology is one of the fastest-growing areas in medical technology, yet we continue to face significant challenges, including total blindness. Emery Pharma’s advanced capabilities in high-resolution mass spectrometry, biomarker discovery, biomarker development, and metabolite analysis offer cutting-edge solutions. These technologies will enable powerful collaborations with companies developing innovative ophthalmic products.”
For more information about Emery Pharma’s participation at the AAO Annual Meeting 2024, or to schedule a meeting with Dr. Najafi at the event, please contact info@emerypharma.com
About Emery Pharma: Emery Pharma is a full-service contract research laboratory, supporting the development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more. Emery Pharma specializes in supporting preclinical drug development, including analytical, bioanalytical solutions, microbiology & cell biology services, drug & impurity characterization, and general CMC and cGMP/GLP support. https://emerypharma.com/contact/
Stay connected with Emery Pharma: Emery Pharma looks forward to connecting with attendees!
Contact us at: +1-510-899-8814 or 1-888-983-6379
Learn more about Emery Pharma: emerypharma.com
Like us on Facebook
Follow us on Twitter
Connect with us on LinkedIn
Avenova® is a registered trademark of NovaBay Pharmaceuticals.